AUG 21, 2016 07:30 AM PDT

Spicy Ginger Nanoparticles to Treat IBD, Colon Cancer

WRITTEN BY: Xuan Pham
A common folk remedy for upset stomachs and other digestive ails often involves ginger – raw, dried, candied, pickled, and as ginger-steeped tea. Now, scientists at the Atlanta Veterans Affairs Medical Center are using 21st century technology to turn ginger into a form that’s never been seen before: ginger-derived nanoparticles. The team hopes this form of ginger will be effective against inflammatory bowel disease and cancer linked to colitis.

Common ginger remedy gets a boost with nanotechnology | Image: pixabay.com
 
Ginger is a gnarly root that has a unique fragrance and spicy taste, making it a popular spice in many Asian cuisines. But what got scientists’ attention to this root were ginger’s anti-inflammatory properties. Some key active compounds in ginger are 6-gingerol and 6-shogaol – chemicals that fight oxidation, inflammation, and cancer. These compounds are why ginger apparently helps with small upset stomachs and other digestive troubles.
 
But for chronic inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, eating ginger isn’t quite enough. The key, scientists believed, was to get the ginger compounds directly to the site of inflammation. This involved a trip to the local farmer’s market, a blender, and some super high-tech centrifugation and ultrasonic dispersion of the ginger bits. In the end, the team arrived at what they called ginger-derived nanoparticles (GDNPs).
 
These nanoparticles each measured at around 230 nanometers in diameter. It’s estimated that the width of a human hair could contain at least 300 of these particles.
 
In lab tests, mice fed with the ginger nanoparticles showed a reduction in acute colon inflammation, which seemed to curb colon cancer in the long term. At the cellular level, the GDNPs seemed to help intestinal cells better fight inflammation and repair itself.
 

The nanoparticle delivery system is a more targeted approach to get the ginger compounds to the intestines. This means a smaller dose could have bigger effects on the inflammation, and side effects on the rest of the body are limited.
 
The team, led by Didier Merlin, is excited at the prospects of turning to the so-called ‘nature’s medicine cabinet’ for potential non-toxic, sustainable, low-cost cures to common diseases. For them, plants represent "nanofactories for the fabrication of medical nanoparticles."

Additional source: Veterans Affairs Research Communications press release
 
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 21, 2019
Cancer
OCT 21, 2019
Combining Breast and Lung Cancer Drugs to Overcome Treatment Resistance
The efforts to overcome cancer’s ability to evolve and resist treatment take many forms and comprise a vital and active branch of contemporary cancer...
OCT 21, 2019
Cancer
OCT 21, 2019
The risks of an inflammatory diet
New research published recently in Nutrients highlights the detriments that an inflammatory diet can have on increasing the risk of certain types of breast...
OCT 21, 2019
Cancer
OCT 21, 2019
New Freezing Technique for Breast Cancer Patients in Low Income Countries
Treatment for breast cancer can be too expensive and hard to access for many women in lower-income countries. These women are disproportionately affected b...
OCT 21, 2019
Cancer
OCT 21, 2019
Vitamin A consumption decreases risk of skin cancer
We know that vitamin A is important for our bodies’ growth and development, in particular for eye, reproductive, and skin health. Now new research sh...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Aspirin: The Good and Bad for Breast Cancer Survivors
Early research has indicated that aspirin usage may increase the survival rate among women with breast cancer. These studies were based on aspirin’s ...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
Loading Comments...